Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US

NACompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

May 13, 2019

Primary Completion Date

September 19, 2019

Study Completion Date

September 19, 2019

Conditions
G6PD Deficiency
Interventions
DIAGNOSTIC_TEST

SD Biosensor G6PD Analyzer

The SD Biosensor G6PD Analyzer is designed to measure the quantitative determination of total hemoglobin concentration and G6PD enzymatic activity in fresh human whole blood specimens based on reflectometry assays in a point-of-care setting. The test is intended to aid in the identification of people with G6PD deficiency. The test is currently not licensed for use in the US and is considered an investigational product.

DIAGNOSTIC_TEST

Pointe Scientific Test Kit

The Pointe Scientific test kit will serve as the reference assay to assess G6PD activity. Its intended use is for the quantitative, kinetic determination of G6PD in blood at 340 nm.

DIAGNOSTIC_TEST

HemoCue System

The HemoCue hemoglobin (Hb) 201+ system is designed for quantitative point-of-care whole blood hemoglobin determination in primary care using a specially designed analyzer, the HemoCue Hb 201+ Analyzer, and specially designed microcuvettes, the HemoCue Hb 201+Microcuvettes.

Trial Locations (1)

98109

Fred Hutchison Prevention Center, Seattle

All Listed Sponsors
collaborator

Fred Hutchinson Cancer Center

OTHER

lead

PATH

OTHER

NCT04010695 - Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US | Biotech Hunter | Biotech Hunter